FDA approves first drug for HIV prophylaxis: Is it right for your patient?

Article Type
Changed
Mon, 01/14/2019 - 11:34
Display Headline
FDA approves first drug for HIV prophylaxis: Is it right for your patient?

The US Food and Drug Administration (FDA) has approved a medication to reduce the risk of sexually acquired human immunodeficiency virus (HIV) infection. Truvada PrEP (emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis) “marks an important milestone in our fight against HIV,” said FDA Commissioner Margaret A. Hamburg, MD.

Truvada PrEP, a tablet taken once daily with or without food, is approved for use in patients ages 12 years and older who are HIV negative—a status to be confirmed by testing before the medication is prescribed and retested every 3 months for the duration of treatment. In addition, it is intended only for individuals at high risk for HIV infection (eg, those whose partners are infected or who have multiple sex partners), as part of a strategy that also includes safer sex practices.

Previously approved for use in combination with other antivirals as a treatment for HIV-positive patients, Truvada’s safety and efficacy in uninfected individuals was demonstrated in 2 large randomized double-blind trials. One study focused primarily on men who have sex with men; the other involved heterosexual men and women with HIV-infected partners. Compared with placebo, Truveda PrEP reduced the risk of HIV infection by 42% among the men who had sex with men, and by 75% among individuals who had infected partners.

The FDA is strengthening Truvada’s black-box warning to help ensure that the PrEP is used as intended. In addition, Gilead Science, which manufactures Truvada, is required to develop a Risk Evaluation and Mitigation Strategy (REMS) for the newly approved prophylaxis. Clinician education is the key component of the REMS, with emphasis on the importance of strict adherence to the once-daily dosing regimen and regular testing intervals to minimize the risk that patients on Truvada PrEP will become infected and that resistant strains of HIV will develop.

Estimates of the cost for Truvada PrEP range from $6,154 to $14,000 per year.1 Gilead has offered to help eligible adults who lack health insurance to obtain Truvada PrEP through its medication assistance program.2

References

1. Kandel S. Infectious Disease Special Edition. FDA approves Truvada for HIV PrEP. July 2012. Available at: http://www.idse.net/ViewArticle.aspx?d=HIV-AIDS%2b%2f%2bSTIs&d_id=214&i=July+2012&i_id=862&a_id=21286. Accessed July 25, 2012.

2. Truvada Medication Assistance Program. Available at: http://www.gilead.com/truvada_assistance_program. Accessed July 25, 2012.

Author and Disclosure Information

Helen Lippman,
Managing Editor

Issue
The Journal of Family Practice - 61(8)
Publications
Topics
Author and Disclosure Information

Helen Lippman,
Managing Editor

Author and Disclosure Information

Helen Lippman,
Managing Editor

The US Food and Drug Administration (FDA) has approved a medication to reduce the risk of sexually acquired human immunodeficiency virus (HIV) infection. Truvada PrEP (emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis) “marks an important milestone in our fight against HIV,” said FDA Commissioner Margaret A. Hamburg, MD.

Truvada PrEP, a tablet taken once daily with or without food, is approved for use in patients ages 12 years and older who are HIV negative—a status to be confirmed by testing before the medication is prescribed and retested every 3 months for the duration of treatment. In addition, it is intended only for individuals at high risk for HIV infection (eg, those whose partners are infected or who have multiple sex partners), as part of a strategy that also includes safer sex practices.

Previously approved for use in combination with other antivirals as a treatment for HIV-positive patients, Truvada’s safety and efficacy in uninfected individuals was demonstrated in 2 large randomized double-blind trials. One study focused primarily on men who have sex with men; the other involved heterosexual men and women with HIV-infected partners. Compared with placebo, Truveda PrEP reduced the risk of HIV infection by 42% among the men who had sex with men, and by 75% among individuals who had infected partners.

The FDA is strengthening Truvada’s black-box warning to help ensure that the PrEP is used as intended. In addition, Gilead Science, which manufactures Truvada, is required to develop a Risk Evaluation and Mitigation Strategy (REMS) for the newly approved prophylaxis. Clinician education is the key component of the REMS, with emphasis on the importance of strict adherence to the once-daily dosing regimen and regular testing intervals to minimize the risk that patients on Truvada PrEP will become infected and that resistant strains of HIV will develop.

Estimates of the cost for Truvada PrEP range from $6,154 to $14,000 per year.1 Gilead has offered to help eligible adults who lack health insurance to obtain Truvada PrEP through its medication assistance program.2

The US Food and Drug Administration (FDA) has approved a medication to reduce the risk of sexually acquired human immunodeficiency virus (HIV) infection. Truvada PrEP (emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis) “marks an important milestone in our fight against HIV,” said FDA Commissioner Margaret A. Hamburg, MD.

Truvada PrEP, a tablet taken once daily with or without food, is approved for use in patients ages 12 years and older who are HIV negative—a status to be confirmed by testing before the medication is prescribed and retested every 3 months for the duration of treatment. In addition, it is intended only for individuals at high risk for HIV infection (eg, those whose partners are infected or who have multiple sex partners), as part of a strategy that also includes safer sex practices.

Previously approved for use in combination with other antivirals as a treatment for HIV-positive patients, Truvada’s safety and efficacy in uninfected individuals was demonstrated in 2 large randomized double-blind trials. One study focused primarily on men who have sex with men; the other involved heterosexual men and women with HIV-infected partners. Compared with placebo, Truveda PrEP reduced the risk of HIV infection by 42% among the men who had sex with men, and by 75% among individuals who had infected partners.

The FDA is strengthening Truvada’s black-box warning to help ensure that the PrEP is used as intended. In addition, Gilead Science, which manufactures Truvada, is required to develop a Risk Evaluation and Mitigation Strategy (REMS) for the newly approved prophylaxis. Clinician education is the key component of the REMS, with emphasis on the importance of strict adherence to the once-daily dosing regimen and regular testing intervals to minimize the risk that patients on Truvada PrEP will become infected and that resistant strains of HIV will develop.

Estimates of the cost for Truvada PrEP range from $6,154 to $14,000 per year.1 Gilead has offered to help eligible adults who lack health insurance to obtain Truvada PrEP through its medication assistance program.2

References

1. Kandel S. Infectious Disease Special Edition. FDA approves Truvada for HIV PrEP. July 2012. Available at: http://www.idse.net/ViewArticle.aspx?d=HIV-AIDS%2b%2f%2bSTIs&d_id=214&i=July+2012&i_id=862&a_id=21286. Accessed July 25, 2012.

2. Truvada Medication Assistance Program. Available at: http://www.gilead.com/truvada_assistance_program. Accessed July 25, 2012.

References

1. Kandel S. Infectious Disease Special Edition. FDA approves Truvada for HIV PrEP. July 2012. Available at: http://www.idse.net/ViewArticle.aspx?d=HIV-AIDS%2b%2f%2bSTIs&d_id=214&i=July+2012&i_id=862&a_id=21286. Accessed July 25, 2012.

2. Truvada Medication Assistance Program. Available at: http://www.gilead.com/truvada_assistance_program. Accessed July 25, 2012.

Issue
The Journal of Family Practice - 61(8)
Issue
The Journal of Family Practice - 61(8)
Publications
Publications
Topics
Article Type
Display Headline
FDA approves first drug for HIV prophylaxis: Is it right for your patient?
Display Headline
FDA approves first drug for HIV prophylaxis: Is it right for your patient?
Article Source

PURLs Copyright

Inside the Article

Primary care access: The view from the trenches

Article Type
Changed
Mon, 01/14/2019 - 11:27
Display Headline
Primary care access: The view from the trenches

When The Journal of Family Practice asked family physicians across the country whether access to primary care was a serious problem in their communities, the answer was a unanimous Yes. Each of the physicians we interviewed is taking steps to increase access. But all agree that the problems contributing to the growing crisis—including a shrinking pool of primary care physicians (PCPs)—are too big to be solved without a national policy shift.

“Physicians owe so much by the time they finish medical school that unless reimbursement is substantially increased, deciding on primary care will be a very difficult decision to make,” says KAROL DAVIS, MD, a family physician (FP) at Heartland Primary Care in Kansas City, Kan.


Karol Davis, MD, Heartland Primary Care, Kansas City, Kan

STANLEY KOZAKOWSKI, MD, director of the Hunterdon Medical Center Family Medicine Residency in Flemington, NJ, echoes Davis’s concern. “We need to address the inequities between the earnings of primary care and non-primary care physicians,” he says, adding that by some accounts, what’s needed is an increase in PCP salaries in the order of 60%.


Stanley Kozakowski, MD, Hunterdon Medical Center Family Medicine Residency, Flemington, NJ

But money is neither the sole problem, nor the sole solution. An advocate of the patient-centered medical home, Kozakowski would end the “hamster wheel model” of practice—in which PCPs squeeze more and more patients into shorter and shorter time slots, but can never catch up. To enable FPs to partner with and coordinate care for their patients, he maintains, “We need to redesign our system to support an advanced primary care model.” In the model he envisions, a PCP’s panel might be closer to 1000 than 2300.

That’s in sharp contrast to the 3300-patient panel of DAVID SWITZER, MD. An FP with Page Healthcare Associates in rural Luray, Va, Switzer has spent the last 12 years in this community, a designated primary care shortage area. “As the population ages and fewer doctors go into primary care,” he says, “the problem is only going to get worse.”


David Switzer, MD, Page Healthcare Associates, Luray, Va

Improving access, 1 practice at a time

While Switzer agrees that “as a society, we need to figure out ways to make it more attractive for physicians to enter primary care disciplines,” he also believes—as do the other FPs we spoke to—that increasing access is the responsibility of individual physicians, too.

With that in mind, his rural practice added 1 full-time and 1 half-time physician a year ago. That increased access in terms of “warm bodies,” Switzer notes, “but we were hampered by space constraints because we had no additional exam rooms.” The solution? The practice instituted staggered schedules, which resulted in opening up earlier in the morning and remaining open a little later in the day.

To further improve access, Switzer and his colleagues implemented an open-access scheduling system. “That has certainly made us more accessible than the conventional scheduling system we previously used,” he acknowledges. “But when you’re limited in terms of capacity, as we are, open access can only go so far.”

If Switzer is not counting on health care reform to fix the PCP access problem, he is hopeful that the recent affliation of his employer, Page Memorial Hospital, with a larger regional health system will make the group more attractive to recruits over the next year or 2. “We now have access to capital to expand the office space, which will help increase our capacity,” he says. Equally helpful is the hospital’s new “convenient care” clinic, adjacent to the emergency department (ED), where patients can go for after-hours care at primary care—not ED—prices.

Heartland Primary Care in Kansas City runs its own urgent care clinic, which is open until 8 pm during the week and until 2 pm on Saturdays and Sundays. Although Davis rotates with several other physicians and nurse practitioners (NPs) in the practice (she works 1 evening a week and 1 weekend a month), after-hours care outside of the hospital is not the norm in their area.

“We routinely see patients at the clinic who have their own PCP, but their doctors close their doors at the end of the day and tell them if they’re sick to go to the ED or to our urgent care clinic, “Davis says. Those who choose the clinic, according to Davis, fare considerably better, in terms of convenience as well as costs: “We’ve gotten the wait down to a point where it’s usually less than 20 minutes,” she says. “At the ED down the street, I’m told, patients can wait as long as 3 hours.”

 

 

Davis has taken additional steps to improve patient access. After having a closed panel for 2 years, she hired an NP to help her work down the backlog and see more patients. Now she’s able to accommodate 2 new patients every workday. “I love meeting new people and would like to accept more new patients,” says Davis. But her panel size—now at 2700—is approaching the point where she may have to close it again.

While some FPs are frustrated by the focus of reform efforts, Davis sees the proposed legislation as an important first step. Another step in the right direction would be to institute reimbursement for electronic patient interactions, she adds, such as those supported by the patient portal Heartland is about to launch. Another key step: Require public and private health plans alike to pay higher fees for after-hours care.

“Plumbers get paid extra for working on Sundays,” Davis points out. “Why shouldn’t we?”

KATE ROWLAND, MD, an FP at Advocate Illinois Masonic Family Medicine Residency in Chicago, says that the residency clinic where she works has taken another step toward increasing access: The group has instituted formal walk-in hours. Between 8 and 10 am, established patients with acute care needs can come in without an appointment and be guaranteed that they’ll be seen by noon.


Kate Rowland, MD, Advocate Illinois Masonic Family Medicine Residency, Chicago

The new approach—a modified version of same-day scheduling—has been tremendously successful, she says, and relieved a good deal of pressure. Still, “We see some 3000 patients per month, and have just gotten busier and busier.”

What else can be done?

Rowland favors taking small steps, 1 at a time: extending clinic hours (it is now open until 7 pm 2 evenings a week and from 8 am until noon on Saturdays); reallocating physician duties, as needed; and establishing classes for patients with similar issues, such as asthma and diabetes, among other innovations.

She maintains, however, that the US health system is devoted to curing disease and prolonging life rather than on keeping the population healthy. A major refocus is needed for lasting change to occur, Rowland says. But will governmental policy changes and physician culture shift in the right direction?

“Medicine is incredibly stagnant,” the 31-year-old Rowland says. “I wonder whether we’ll still have the same chaotic system when I’m ready to retire.”

Article PDF
Author and Disclosure Information

Helen Lippman, Managing Editor

Issue
The Journal of Family Practice - 58(12)
Publications
Page Number
637-638
Sections
Author and Disclosure Information

Helen Lippman, Managing Editor

Author and Disclosure Information

Helen Lippman, Managing Editor

Article PDF
Article PDF

When The Journal of Family Practice asked family physicians across the country whether access to primary care was a serious problem in their communities, the answer was a unanimous Yes. Each of the physicians we interviewed is taking steps to increase access. But all agree that the problems contributing to the growing crisis—including a shrinking pool of primary care physicians (PCPs)—are too big to be solved without a national policy shift.

“Physicians owe so much by the time they finish medical school that unless reimbursement is substantially increased, deciding on primary care will be a very difficult decision to make,” says KAROL DAVIS, MD, a family physician (FP) at Heartland Primary Care in Kansas City, Kan.


Karol Davis, MD, Heartland Primary Care, Kansas City, Kan

STANLEY KOZAKOWSKI, MD, director of the Hunterdon Medical Center Family Medicine Residency in Flemington, NJ, echoes Davis’s concern. “We need to address the inequities between the earnings of primary care and non-primary care physicians,” he says, adding that by some accounts, what’s needed is an increase in PCP salaries in the order of 60%.


Stanley Kozakowski, MD, Hunterdon Medical Center Family Medicine Residency, Flemington, NJ

But money is neither the sole problem, nor the sole solution. An advocate of the patient-centered medical home, Kozakowski would end the “hamster wheel model” of practice—in which PCPs squeeze more and more patients into shorter and shorter time slots, but can never catch up. To enable FPs to partner with and coordinate care for their patients, he maintains, “We need to redesign our system to support an advanced primary care model.” In the model he envisions, a PCP’s panel might be closer to 1000 than 2300.

That’s in sharp contrast to the 3300-patient panel of DAVID SWITZER, MD. An FP with Page Healthcare Associates in rural Luray, Va, Switzer has spent the last 12 years in this community, a designated primary care shortage area. “As the population ages and fewer doctors go into primary care,” he says, “the problem is only going to get worse.”


David Switzer, MD, Page Healthcare Associates, Luray, Va

Improving access, 1 practice at a time

While Switzer agrees that “as a society, we need to figure out ways to make it more attractive for physicians to enter primary care disciplines,” he also believes—as do the other FPs we spoke to—that increasing access is the responsibility of individual physicians, too.

With that in mind, his rural practice added 1 full-time and 1 half-time physician a year ago. That increased access in terms of “warm bodies,” Switzer notes, “but we were hampered by space constraints because we had no additional exam rooms.” The solution? The practice instituted staggered schedules, which resulted in opening up earlier in the morning and remaining open a little later in the day.

To further improve access, Switzer and his colleagues implemented an open-access scheduling system. “That has certainly made us more accessible than the conventional scheduling system we previously used,” he acknowledges. “But when you’re limited in terms of capacity, as we are, open access can only go so far.”

If Switzer is not counting on health care reform to fix the PCP access problem, he is hopeful that the recent affliation of his employer, Page Memorial Hospital, with a larger regional health system will make the group more attractive to recruits over the next year or 2. “We now have access to capital to expand the office space, which will help increase our capacity,” he says. Equally helpful is the hospital’s new “convenient care” clinic, adjacent to the emergency department (ED), where patients can go for after-hours care at primary care—not ED—prices.

Heartland Primary Care in Kansas City runs its own urgent care clinic, which is open until 8 pm during the week and until 2 pm on Saturdays and Sundays. Although Davis rotates with several other physicians and nurse practitioners (NPs) in the practice (she works 1 evening a week and 1 weekend a month), after-hours care outside of the hospital is not the norm in their area.

“We routinely see patients at the clinic who have their own PCP, but their doctors close their doors at the end of the day and tell them if they’re sick to go to the ED or to our urgent care clinic, “Davis says. Those who choose the clinic, according to Davis, fare considerably better, in terms of convenience as well as costs: “We’ve gotten the wait down to a point where it’s usually less than 20 minutes,” she says. “At the ED down the street, I’m told, patients can wait as long as 3 hours.”

 

 

Davis has taken additional steps to improve patient access. After having a closed panel for 2 years, she hired an NP to help her work down the backlog and see more patients. Now she’s able to accommodate 2 new patients every workday. “I love meeting new people and would like to accept more new patients,” says Davis. But her panel size—now at 2700—is approaching the point where she may have to close it again.

While some FPs are frustrated by the focus of reform efforts, Davis sees the proposed legislation as an important first step. Another step in the right direction would be to institute reimbursement for electronic patient interactions, she adds, such as those supported by the patient portal Heartland is about to launch. Another key step: Require public and private health plans alike to pay higher fees for after-hours care.

“Plumbers get paid extra for working on Sundays,” Davis points out. “Why shouldn’t we?”

KATE ROWLAND, MD, an FP at Advocate Illinois Masonic Family Medicine Residency in Chicago, says that the residency clinic where she works has taken another step toward increasing access: The group has instituted formal walk-in hours. Between 8 and 10 am, established patients with acute care needs can come in without an appointment and be guaranteed that they’ll be seen by noon.


Kate Rowland, MD, Advocate Illinois Masonic Family Medicine Residency, Chicago

The new approach—a modified version of same-day scheduling—has been tremendously successful, she says, and relieved a good deal of pressure. Still, “We see some 3000 patients per month, and have just gotten busier and busier.”

What else can be done?

Rowland favors taking small steps, 1 at a time: extending clinic hours (it is now open until 7 pm 2 evenings a week and from 8 am until noon on Saturdays); reallocating physician duties, as needed; and establishing classes for patients with similar issues, such as asthma and diabetes, among other innovations.

She maintains, however, that the US health system is devoted to curing disease and prolonging life rather than on keeping the population healthy. A major refocus is needed for lasting change to occur, Rowland says. But will governmental policy changes and physician culture shift in the right direction?

“Medicine is incredibly stagnant,” the 31-year-old Rowland says. “I wonder whether we’ll still have the same chaotic system when I’m ready to retire.”

When The Journal of Family Practice asked family physicians across the country whether access to primary care was a serious problem in their communities, the answer was a unanimous Yes. Each of the physicians we interviewed is taking steps to increase access. But all agree that the problems contributing to the growing crisis—including a shrinking pool of primary care physicians (PCPs)—are too big to be solved without a national policy shift.

“Physicians owe so much by the time they finish medical school that unless reimbursement is substantially increased, deciding on primary care will be a very difficult decision to make,” says KAROL DAVIS, MD, a family physician (FP) at Heartland Primary Care in Kansas City, Kan.


Karol Davis, MD, Heartland Primary Care, Kansas City, Kan

STANLEY KOZAKOWSKI, MD, director of the Hunterdon Medical Center Family Medicine Residency in Flemington, NJ, echoes Davis’s concern. “We need to address the inequities between the earnings of primary care and non-primary care physicians,” he says, adding that by some accounts, what’s needed is an increase in PCP salaries in the order of 60%.


Stanley Kozakowski, MD, Hunterdon Medical Center Family Medicine Residency, Flemington, NJ

But money is neither the sole problem, nor the sole solution. An advocate of the patient-centered medical home, Kozakowski would end the “hamster wheel model” of practice—in which PCPs squeeze more and more patients into shorter and shorter time slots, but can never catch up. To enable FPs to partner with and coordinate care for their patients, he maintains, “We need to redesign our system to support an advanced primary care model.” In the model he envisions, a PCP’s panel might be closer to 1000 than 2300.

That’s in sharp contrast to the 3300-patient panel of DAVID SWITZER, MD. An FP with Page Healthcare Associates in rural Luray, Va, Switzer has spent the last 12 years in this community, a designated primary care shortage area. “As the population ages and fewer doctors go into primary care,” he says, “the problem is only going to get worse.”


David Switzer, MD, Page Healthcare Associates, Luray, Va

Improving access, 1 practice at a time

While Switzer agrees that “as a society, we need to figure out ways to make it more attractive for physicians to enter primary care disciplines,” he also believes—as do the other FPs we spoke to—that increasing access is the responsibility of individual physicians, too.

With that in mind, his rural practice added 1 full-time and 1 half-time physician a year ago. That increased access in terms of “warm bodies,” Switzer notes, “but we were hampered by space constraints because we had no additional exam rooms.” The solution? The practice instituted staggered schedules, which resulted in opening up earlier in the morning and remaining open a little later in the day.

To further improve access, Switzer and his colleagues implemented an open-access scheduling system. “That has certainly made us more accessible than the conventional scheduling system we previously used,” he acknowledges. “But when you’re limited in terms of capacity, as we are, open access can only go so far.”

If Switzer is not counting on health care reform to fix the PCP access problem, he is hopeful that the recent affliation of his employer, Page Memorial Hospital, with a larger regional health system will make the group more attractive to recruits over the next year or 2. “We now have access to capital to expand the office space, which will help increase our capacity,” he says. Equally helpful is the hospital’s new “convenient care” clinic, adjacent to the emergency department (ED), where patients can go for after-hours care at primary care—not ED—prices.

Heartland Primary Care in Kansas City runs its own urgent care clinic, which is open until 8 pm during the week and until 2 pm on Saturdays and Sundays. Although Davis rotates with several other physicians and nurse practitioners (NPs) in the practice (she works 1 evening a week and 1 weekend a month), after-hours care outside of the hospital is not the norm in their area.

“We routinely see patients at the clinic who have their own PCP, but their doctors close their doors at the end of the day and tell them if they’re sick to go to the ED or to our urgent care clinic, “Davis says. Those who choose the clinic, according to Davis, fare considerably better, in terms of convenience as well as costs: “We’ve gotten the wait down to a point where it’s usually less than 20 minutes,” she says. “At the ED down the street, I’m told, patients can wait as long as 3 hours.”

 

 

Davis has taken additional steps to improve patient access. After having a closed panel for 2 years, she hired an NP to help her work down the backlog and see more patients. Now she’s able to accommodate 2 new patients every workday. “I love meeting new people and would like to accept more new patients,” says Davis. But her panel size—now at 2700—is approaching the point where she may have to close it again.

While some FPs are frustrated by the focus of reform efforts, Davis sees the proposed legislation as an important first step. Another step in the right direction would be to institute reimbursement for electronic patient interactions, she adds, such as those supported by the patient portal Heartland is about to launch. Another key step: Require public and private health plans alike to pay higher fees for after-hours care.

“Plumbers get paid extra for working on Sundays,” Davis points out. “Why shouldn’t we?”

KATE ROWLAND, MD, an FP at Advocate Illinois Masonic Family Medicine Residency in Chicago, says that the residency clinic where she works has taken another step toward increasing access: The group has instituted formal walk-in hours. Between 8 and 10 am, established patients with acute care needs can come in without an appointment and be guaranteed that they’ll be seen by noon.


Kate Rowland, MD, Advocate Illinois Masonic Family Medicine Residency, Chicago

The new approach—a modified version of same-day scheduling—has been tremendously successful, she says, and relieved a good deal of pressure. Still, “We see some 3000 patients per month, and have just gotten busier and busier.”

What else can be done?

Rowland favors taking small steps, 1 at a time: extending clinic hours (it is now open until 7 pm 2 evenings a week and from 8 am until noon on Saturdays); reallocating physician duties, as needed; and establishing classes for patients with similar issues, such as asthma and diabetes, among other innovations.

She maintains, however, that the US health system is devoted to curing disease and prolonging life rather than on keeping the population healthy. A major refocus is needed for lasting change to occur, Rowland says. But will governmental policy changes and physician culture shift in the right direction?

“Medicine is incredibly stagnant,” the 31-year-old Rowland says. “I wonder whether we’ll still have the same chaotic system when I’m ready to retire.”

Issue
The Journal of Family Practice - 58(12)
Issue
The Journal of Family Practice - 58(12)
Page Number
637-638
Page Number
637-638
Publications
Publications
Article Type
Display Headline
Primary care access: The view from the trenches
Display Headline
Primary care access: The view from the trenches
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media